Art. 19 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 3×

In order to examine the application submitted in accordance with Articles 8, 10, 10a, 10b and 10c, the competent authority of the Member State:

1.

must verify whether the particulars submitted in support of the application comply with the said Articles 8, 10, 10a, 10b and 10c and examine whether the conditions for issuing an authorization to place medicinal products on the market (marketing authorization) are complied with.

2.

may submit the medicinal product, its starting materials and, if need be, its intermediate products or other constituent materials, for testing by an Official Medicines Control Laboratory or a laboratory that a Member State has designated for that purpose in order to ensure that the control methods employed by the manufacturer and described in the particulars accompanying the application in accordance with Article 8(3)(h) are satisfactory.

3.

may, where appropriate, require the applicant to supplement the particulars accompanying the application in respect of the items listed in the Articles 8(3), 10, 10a, 10b and 10c. Where the competent authority avails itself of this option, the time limits laid down in Article 17 shall be suspended until such time as the supplementary information required has been provided. Likewise, these time limits shall be suspended for the time allowed the applicant, where appropriate, for giving oral or written explanation.

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Second Chamber) of 14 March 2018. Proceedings brought by Astellas Pharma GmbH.Decision

    Secondly, it is clear from Article 19(1) of Directive 2001/83 that, in order to examine an application under Article 10 of that directive, the competent authority of a Member State must verify whether the file submitted complies with that …

    14 Mar 2018 · 62016CJ0557

  • Opinion of Mr Advocate General Bot delivered on 10 July 2008. The Queen, on the application of Synthon BV v Licensing Authority of the DeparDecision

    Contrary to the role it plays in the context of examination of an application for marketing authorisation under Article 19 of Directive 2001/83, the powers of the Member State dealing with an application for mutual recognition are …

    10 Jul 2008 · 62006CC0452